Black Diamond Therapeutics, Inc. (BDTX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-29

Black Diamond Therapeutics, Inc. (BDTX) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-29. 3 Form 8-K material event filings were reported by BDTX in the last 90 days. InsiderAlpha tracks every BDTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Black Diamond Therapeutics, Inc. (BDTX)

SEC CIK	0001701541

90-Day SEC Filing Activity

Form 4 filings (90d)	8
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-06-29

Recent BDTX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-06-19	Behbahani Ali	Insider	A — Grant or award	9.0K	$1.66	$15K	SEC
2026-06-19	Raman Prakash	Insider	A — Grant or award	7.9K	$1.66	$13K	SEC
2026-03-20	Raman Prakash	Insider	A — Grant or award	6.1K	$2.15	$13K	SEC
2026-03-20	Behbahani Ali	Insider	A — Grant or award	6.9K	$2.15	$15K	SEC
2025-09-19	Behbahani Ali	Insider	A — Grant or award	4.3K	$3.35	$14K	SEC
2025-09-19	Raman Prakash	Insider	A — Grant or award	3.8K	$3.35	$13K	SEC
2024-12-13	Raman Prakash	Insider	A — Grant or award	5.2K	$2.50	$13K	SEC
2024-12-13	Campbell Shannon	Insider	A — Grant or award	4.5K	$2.50	$11K	SEC
2024-12-13	Behbahani Ali	Insider	A — Grant or award	5.8K	$2.50	$14K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Black Diamond Therapeutics, Inc. (BDTX). Updated in real time as new filings are submitted to the SEC.

Most-Active BDTX Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Behbahani Ali	2	$15K
Raman Prakash	2	$13K
Kulkarni Samarth	1	—
Dhingra Kapil	1	—
Campbell Shannon	1	—

Recent BDTX Form 8-K Material Events

2026-06-29 — Item 5.07 [SEC]
2026-05-21 — Item 7.01, 8.01, 9.01 [SEC]
2026-05-07 — Item 2.02, 9.01 [SEC]
2026-03-16 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Black Diamond Therapeutics announced its financial results for the year and three months ended December 31, 2025 on March 16, 2026. The filing provides standard results of operations and financial condition disclosure without indicating whether results beat or missed expectations

Recent Insider Filings

2026-06-29 — Behbahani Ali (Insider)
2026-06-29 — Kulkarni Samarth (Insider)
2026-06-29 — Menzel Garry E (Insider)
2026-06-29 — Raman Prakash (Insider)
2026-06-29 — Dhingra Kapil (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in BDTX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

BDTX Insider Trading — FAQ

What is the latest insider trade for BDTX?: Black Diamond Therapeutics, Inc. (BDTX) had 8 insider filings in the last 90 days, with the most recent on 2026-06-29. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying BDTX stock?: 0 insider purchases of BDTX were filed in the last 90 days.
How many insiders are selling BDTX stock?: 0 insider sales of BDTX were filed in the last 90 days.
Where can I see BDTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every BDTX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live BDTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.